DR. T. LEBON

Active

Private limited companyfounded 1989active for 37 yearsGestelsesteenweg 111, 2450 Meerhout, BelgiumKBO/BCE: BE 0438.581.837

From the official registers: KBO 37 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. T. LEBON has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €286,811 and a net result of €63,735. Equity is growing by about 3.4% per year across the filed financial years. Its solvency ranks better than 75% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

DR. T. LEBONActiveChecked score 90/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 05-10-1989 Normal situation
Legal form: Private limited company
Registered office: Gestelsesteenweg 111, 2450 Meerhout
Activity: Scientific research and development NACE 72200
Establishment unit: 2.228.679.819 2450 Meerhout, since 05-10-1989
Financial year end: 31 December
Peppol: Reachable since 04-12-2025

Company details

Who decides

Board

LEBON TheoDirector

Holdings: Shares in 2 companies Practimed and W-CUP

Board & ownership

How it is doing

90 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Annual accounts 2025

Gross margin: €111,863; ▼ 26.6%
Turnover: ≈ €280,000; estimated
Profit: €63,735
Equity: €286,811; ▲ 28.6%
Total assets: €369,734; ▼ 2.7%

2025 accounts 3 days early

Filed on 28-07-2026at the National Bank

Financials

Why 90raises risk1 of the last 3 lateLiquidity: current ratio 0.27, cash €3,969lowers riskFounded in 1989Figures for financial year 2025 (filed 28-07-2026)Show the evidence

Checked score

Score 2025

90 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 64% of its sector peers (NACE 72, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100+16

equity 77.6% of total assets

Liquidity 44+13

short-term debt 22.4% · cash 1.1%

Profitability 90+90

return on assets 17.2%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)

Last 24 months 11-2024: 0.2%lowest value 12-2024: 0.2%● unchanged vs 11-2024lowest value 01-2025: 0.2%● unchanged vs 12-2024lowest value 02-2025: 0.2%● unchanged vs 01-2025lowest value 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.2 percentage points vs 06-2025 08-2025: 0.7%▲ +0.3 percentage points vs 07-2025 09-2025: 0.8%▲ +0.1 percentage points vs 08-2025 10-2025: 1.4%▲ +0.6 percentage points vs 09-2025 11-2025: 1.4%● unchanged vs 10-2025 12-2025: 1.4%● unchanged vs 11-2025 01-2026: 1.4%● unchanged vs 12-2025 02-2026: 1.4%● unchanged vs 01-2026 03-2026: 1.3%▼ -0.1 percentage points vs 02-2026 04-2026: 1.3%● unchanged vs 03-2026 05-2026: 1.3%● unchanged vs 04-2026 06-2026: 1.4%▲ +0.1 percentage points vs 05-2026 07-2026: 1.5%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 0.2%▼ -1.3 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026

Credit of up to €25,000 on 30-day terms is acceptable

Liquidity insufficient (current ratio 0.27, compared with 0.07 in 2024, below 1; short-term debt: 22.4% and cash: 1.1% of total assets), and 22.4% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 83% on solvency, 21% on liquidity, 71% on profitability and 80% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

1 of the last 3 late

NBB · filings

Founded in 1989

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Liquidity: current ratio 0.27, cash €3,969

NBB · annual accounts

Figures for financial year 2025 (filed 28-07-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

3 days early

2024

60 days late

2023

34 days early

2022

32 days early

2021

17 days late

2020

33 days early

2019

32 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 8 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 July (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Back in profit in 2025after -€417,619 in 2024 €63,735 View
Positive: Oldest company in Meerhout, Professional and technical services sectorin the Checked rankings No. 1 View

Documents

Key facts about DR. T. LEBON

What is the company number of DR. T. LEBON?: 0438.581.837. In Belgium the VAT number is the company number with BE in front: BE 0438.581.837.
Where is DR. T. LEBON based?: The registered office is at Gestelsesteenweg 111, 2450 Meerhout.Company details
What does DR. T. LEBON do?: According to the KBO register, the main activity is scientific research and development (NACE 72200).
What is the legal form of DR. T. LEBON?: Private limited company (BV).
When was DR. T. LEBON founded?: On 05-10-1989.
Is DR. T. LEBON still active?: Yes, DR. T. LEBON is an active enterprise in the KBO register.
What is the turnover of DR. T. LEBON?: ≈ €280,000 in financial year 2025. Estimated from the gross margin of €111,863: probably between €170,000 and €530,000, based on 1,644 comparable companies of the same size. A rough estimate.Financials
Is DR. T. LEBON profitable?: In financial year 2025, DR. T. LEBON made a profit of €63,735.
Where can I find the annual accounts of DR. T. LEBON?: DR. T. LEBON filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. T. LEBON due?: By 31-07-2027, for financial year 2026.Timeline